COXHEALTH
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1M
- Transactions
- 748
- Companies
- 40
- Average per transaction
- $1,402
Who reported the payments
| Boston Scientific | $176,722 |
| AbbVie | $58,900 |
| Insulet Corporation | $58,175 |
| Janssen Research & Development, LLC | $57,343 |
| Merck | $55,623 |
| Medtronic | $55,124 |
| Genentech, Inc. | $54,820 |
| Novartis | $51,347 |
| W. L. Gore & Associates, Inc. | $42,600 |
| Stryker | $31,490 |
| Amgen | $30,810 |
| Boehringer Ingelheim | $26,564 |
| Zimmer Biomet | $24,291 |
| Terumo Medical Corporation | $22,331 |
| Sterilmed, Inc. | $18,164 |
| AstraZeneca | $16,856 |
| Vapotherm Inc | $16,711 |
| MDD US Operations, LLC | $16,409 |
| Tandem Diabetes Care, Inc. | $15,925 |
| Johnson & Johnson | $13,822 |
| Abbott | $12,742 |
| Lantheus Medical Imaging, Inc. | $11,850 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $11,850 |
| Biotronik Inc. | $10,859 |
| United Therapeutics Corporation | $10,805 |
| E.r. Squibb & Sons, L.L.C. | $9,949 |
| Olympus America Inc. | $9,887 |
| Barco, Inc. | $8,000 |
| Bard Peripheral Vascular, Inc. | $7,754 |
| Bayer | $6,495 |
| BD | $6,000 |
| Neurocrine Biosciences, Inc. | $5,850 |
| Baxter Healthcare | $5,754 |
| Siemens Medical Solutions USA, Inc. | $5,700 |
| Novo Nordisk | $5,000 |
| Genentech USA, Inc. | $4,450 |
| Otsuka America Pharmaceutical, Inc. | $4,400 |
| Pfizer | $3,790 |
| Penumbra, Inc. | $3,750 |
| Medline Industries LP | $3,639 |